Legacy Capital Partners Inc. trimmed its position in Colgate-Palmolive (NYSE:CL) by 3.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 54,806 shares of the company’s stock after selling 1,750 shares during the quarter. Colgate-Palmolive makes up 2.0% of Legacy Capital Partners Inc.’s portfolio, making the stock its 13th biggest position. Legacy Capital Partners Inc.’s holdings in Colgate-Palmolive were worth $4,135,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Blue Chip Partners Inc. lifted its stake in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the last quarter. AlphaMark Advisors LLC lifted its stake in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the last quarter. Weatherstone Capital Management lifted its stake in shares of Colgate-Palmolive by 0.7% during the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its stake in shares of Colgate-Palmolive by 0.6% during the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after purchasing an additional 34 shares during the last quarter. Finally, Jackson Grant Investment Advisers Inc. lifted its stake in shares of Colgate-Palmolive by 0.5% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after purchasing an additional 35 shares during the last quarter. Institutional investors and hedge funds own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (NYSE CL) opened at $71.46 on Friday. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 12 month low of $68.19 and a 12 month high of $77.91. The company has a market capitalization of $62,550.87, a PE ratio of 31.34, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
CL has been the subject of a number of analyst reports. Citigroup decreased their price objective on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Monday, October 23rd. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 price objective on Colgate-Palmolive and gave the stock a “hold” rating in a research note on Sunday, October 29th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $77.71.
In other news, COO Noel R. Wallace sold 126,304 shares of the stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the transaction, the chief operating officer now directly owns 305,631 shares of the company’s stock, valued at $22,549,455.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman Franck J. Moison sold 142,979 shares of the stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total value of $10,021,398.11. Following the completion of the transaction, the insider now directly owns 224,027 shares in the company, valued at $15,702,052.43. The disclosure for this sale can be found here. Insiders sold 421,019 shares of company stock worth $30,031,097 over the last three months. Corporate insiders own 1.02% of the company’s stock.
WARNING: This news story was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://stocknewstimes.com/2018/02/18/legacy-capital-partners-inc-lowers-holdings-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.